US tech company looks to buy Renergen

ASP Isotopes, an advanced materials company currently listed on the NASDAQ, has made an offer to buy South African gas company Renergen.

ASP Isotopes is a development-stage advanced materials company dedicated to developing technology and processes for the production of isotopes for use in multiple industries.

Specifically, ASP Isotopes employs proprietary technology, the Aerodynamic Separation Process. 

The company’s initial focus is on producing and commercialising highly enriched isotopes for the healthcare and technology industries. 

It also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the company is developing.

On Tuesday, 20 May 2025, Renergen informed shareholders that ASP Isotopes has offered to acquire 100% of Renergen’s ordinary shares in Renergen by way of a scheme of arrangement or a standby general offer.

“This is an exciting step for ASP Isotopes. With the imminent Spin-Out of QLE, I have been considering the expansion of the ASP Isotopes business, and this opportunity is the perfect fit for us,” ASP Isotopes CEO and chairman Paul Mann said.

“Both isotopes and helium are viewed by many governments as critically and strategically important materials.” 

“The combination of these two companies will create a company with huge strategic value and a vital part of a fragile supply chain, enabling so many industries.” 

Renergen CEO Stefano Marani said he is excited about the combined prospects of his new company and its future.

“Access to the US Investor base who have a deep understanding of critical minerals, as well as oil and gas, has for the longest time been the final critical ingredient required to unlock the Virginia Gas Project and the longer-term expansion of this unique natural resource,” he said. 

“In joining our two companies, not only do we get this, but even more exciting is the expansion of the business horizontally across our key helium customer bases of nuclear, healthcare, semiconductors and rocketry.” 

“As the world becomes more insular, critical materials are quickly becoming the most sought-after commodities, and our merger places ASP Isotopes Inc. front and centre.” 

This development comes after ASP Isotopes recently announced that it is set to list on the Johannesburg Stock Exchange (JSE) later this year.

ASPI’s history and technology are firmly rooted in South Africa. It has three plants in Pretoria, refining the commercial production of Carbon-14, Silicon-28, and Ytterbium-176.

These resources are used across the pharmaceutical, medical, quantum computing, and semiconductor industries.

Listed on the JSE, Renergen has previously come under fire for missing many of its own deadlines and shareholder promises in terms of its helium production and poor financial performance.

The announcement of this sale has seen the company’s share price surge by over 70% on Tuesday, 20 May, at around 14:00.